Leading Financial Service Provider in India | Canara Bank Securities Ltd

Vanta Bioscience Ltd.

Jun 05 BSE 26.80 (+ 0.52 1.98%)

Volume1500

Prev. Close
26.28

Open Price
26.80

Today's Low / High

26.80 26.80

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

19.08 64.84

Vanta Bioscience Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	19.06	P/BV	1.37	Book Value ( ₹ )	19.59
52 Week High/Low ( ₹ )	65/19	FV/ML	10/750	P/E(X)	0.00
Book Closure		EPS ( ₹ )	0.00	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	63.12	63.12	63.12	63.12	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31	6.31	6.31	6.31	6.31
Total Share Capital	6.31	6.31	6.31	6.31	6.31

Reserves and Surplus	8.89	11.20	17.70	17.61	17.16
Total Reserves and Surplus	8.89	11.20	17.70	17.61	17.16
Total Shareholders Funds	15.20	17.51	24.01	23.92	23.47
Minority Interest	-2.23	1.41	5.34	2.31	0.99

NON-CURRENT LIABILITIES
Long Term Borrowings	48.80	47.07	37.00	27.84	13.65
Deferred Tax Liabilities [Net]	0.75	0.97	0.78	0.72	0.59
Total Non-Current Liabilities	49.55	48.03	37.78	28.56	14.24

CURRENT LIABILITIES
Short Term Borrowings	12.15	10.09	7.87	4.15	1.88
Trade Payables	5.57	4.22	2.46	0.47	0.49
Other Current Liabilities	5.16	3.43	3.91	10.16	7.42
Short Term Provisions	0.00	0.00	0.04	0.06	0.08
Total Current Liabilities	22.88	17.75	14.28	14.84	9.87

Total Capital And Liabilities	85.40	84.71	81.40	69.63	48.57

ASSETS
NON-CURRENT ASSETS
Tangible Assets	28.41	33.23	14.54	15.52	15.89
Intangible Assets	25.75	24.00	21.59	0.00	0.00
Capital Work-In-Progress	0.00	0.00	22.78	19.34	7.00
Intangible Assets Under Development	12.53	10.60	5.69	0.00	0.00
Other Assets	0.00	0.00	0.00	13.87	4.86
Fixed Assets	66.69	67.83	64.59	48.73	27.76
Other Non-Current Assets	1.55	1.64	2.32	0.97	0.97
Total Non-Current Assets	68.24	69.47	66.91	49.69	28.73


CURRENT ASSETS
Inventories	7.52	7.16	7.24	9.76	14.01
Trade Receivables	3.14	1.96	1.13	2.01	1.39
Cash And Cash Equivalents	0.16	0.10	0.22	2.65	0.20
Short Term Loans And Advances	5.77	5.38	5.18	4.87	3.92
OtherCurrentAssets	0.56	0.65	0.72	0.64	0.33
Total Current Assets	17.16	15.24	14.50	19.94	19.85

Total Assets	85.40	84.71	81.40	69.63	48.57

Particulars	Mar 24
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31
Total Share Capital	6.31
Reserves and Surplus	8.89
Total Reserves and Surplus	8.89
Total Shareholders Funds	15.20
Minority Interest	-2.23
NON-CURRENT LIABILITIES
Long Term Borrowings	48.80
Deferred Tax Liabilities [Net]	0.75
Total Non-Current Liabilities	49.55
CURRENT LIABILITIES
Short Term Borrowings	12.15
Trade Payables	5.57
Other Current Liabilities	5.16
Short Term Provisions	0.00
Total Current Liabilities	22.88
Total Capital And Liabilities	85.40
ASSETS
NON-CURRENT ASSETS
Tangible Assets	28.41
Intangible Assets	25.75
Capital Work-In-Progress	0.00
Intangible Assets Under Development	12.53
Other Assets	0.00
Fixed Assets	66.69
Other Non-Current Assets	1.55
Total Non-Current Assets	68.24
CURRENT ASSETS
Inventories	7.52
Trade Receivables	3.14
Cash And Cash Equivalents	0.16
Short Term Loans And Advances	5.77
OtherCurrentAssets	0.56
Total Current Assets	17.16
Total Assets	85.40

Markets

Balance Sheet

BALANCE SHEET

Vanta Bioscience Ltd.